These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24345252)

  • 1. Interview: a 20-year 'search for evidence' leads to the Center for Medical Technology Policy.
    Tunis SR
    J Comp Eff Res; 2014 Jan; 3(1):11-6. PubMed ID: 24345252
    [No Abstract]   [Full Text] [Related]  

  • 2. Valid clinical research and reimbursement for what we do.
    Hillman BJ
    J Am Coll Radiol; 2005 Jan; 2(1):3-4. PubMed ID: 17411751
    [No Abstract]   [Full Text] [Related]  

  • 3. Values and evidence colliding: health technology assessment in child health.
    Ungar WJ; Prosser LA; Burnett HF
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):417-9. PubMed ID: 23977967
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative effectiveness and the European pharmaceutical market.
    Jönsson B
    Eur J Health Econ; 2011 Apr; 12(2):97-102. PubMed ID: 21267624
    [No Abstract]   [Full Text] [Related]  

  • 5. The Blue Cross Blue Shield Association Technology Evaluation Center: how we evaluate radiology technologies.
    Ziegler KM; Flamm CR; Aronson N
    J Am Coll Radiol; 2005 Jan; 2(1):33-8. PubMed ID: 17411757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH.
    Moloney R; Mohr P; Hawe E; Shah K; Garau M; Towse A
    Int J Technol Assess Health Care; 2015 Jan; 31(1-2):90-8. PubMed ID: 26168804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comment: Hurdles for comparative effectiveness research in Germany].
    Sawicki PT
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(7):492-5. PubMed ID: 22981025
    [No Abstract]   [Full Text] [Related]  

  • 8. Real-World Evidence of Treatment Effects: The Useful and the Misleading.
    Schneeweiss S
    Clin Pharmacol Ther; 2019 Jul; 106(1):43-44. PubMed ID: 30942896
    [No Abstract]   [Full Text] [Related]  

  • 9. A proposal for improving evidence generation in nephrology.
    Mendelssohn DC; Manns BJ
    Am J Kidney Dis; 2011 Jul; 58(1):13-8. PubMed ID: 21458897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What outcomes should US policy makers compare in comparative effectiveness research?
    Bridges JF; Buttorff C
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):217-20. PubMed ID: 20545584
    [No Abstract]   [Full Text] [Related]  

  • 11. Interview: Health technology assessment in Asia: an emerging trend.
    Yang BM
    J Comp Eff Res; 2012 May; 1(3):221-4. PubMed ID: 24237405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmonization of evidence requirements for health technology assessment in reimbursement decision making.
    Hutton J; Trueman P; Facey K
    Int J Technol Assess Health Care; 2008; 24(4):511-7. PubMed ID: 18828948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Authority for Health: France.
    Rochaix L; Xerri B
    Issue Brief (Commonw Fund); 2009 Jul; 58():1-9. PubMed ID: 19639712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainties in real-world decisions on medical technologies.
    Lu CY
    Int J Clin Pract; 2014 Aug; 68(8):936-40. PubMed ID: 25074335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness research: what does it mean for imaging?
    Carlos RC
    Acad Radiol; 2010 Sep; 17(9):1071-2. PubMed ID: 20692618
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing medical technology and business opportunities.
    Sarma RK; Kapoor P; Gupta AK
    J Acad Hosp Adm; 1996 Jul-1997 Jan; 8-9(2-1):57-61. PubMed ID: 10166964
    [No Abstract]   [Full Text] [Related]  

  • 17. Technology assessment is performed by payers, too.
    Mitchell MD
    Radiology; 2008 Mar; 246(3):984-5. PubMed ID: 18309024
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effectiveness: beyond the buzz.
    Annemans L
    J Med Econ; 2012; 15(6):1036-8. PubMed ID: 23157667
    [No Abstract]   [Full Text] [Related]  

  • 19. Introduction of emerging medical devices on the market: a new procedure in Belgium.
    Vinck I; Neyt M; Thiry N; Louagie M; Ramaekers D
    Int J Technol Assess Health Care; 2007; 23(4):449-54. PubMed ID: 17937833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring technological competence and leadership in medicine.
    McGivney WT
    Physician Exec; 1993; 19(1):50-1. PubMed ID: 10125939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.